Summary & Overview

HCPCS Level II J1790: Injection, Droperidol, up to 5 mg

HCPCS Level II code J1790 denotes the injectable administration of droperidol, up to 5 mg. This code is used to bill a single dose of droperidol, an antiemetic and antipsychotic agent commonly given in acute care settings such as emergency departments, perioperative units, and ambulatory surgical centers. Accurate coding for injectable medications like J1790 matters nationally because it affects medication tracking, cost reporting, and claims adjudication across payers.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what J1790 represents, payer coverage considerations, typical sites of service, and the clinical context in which droperidol is administered. The publication outlines billing benchmarks, common modifiers used with injectable drug codes, and policy updates that influence reimbursement and documentation requirements. Clinical context covers indications for droperidol use, typical dosing limitations tied to the code, and operational considerations for administering a single injectable dose.

Data not available in the input is noted where applicable, and the content is presented for a national audience without state-specific references.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ1790HCPCS Level IIdroperidolinjectable medicationmedication administrationemergency medicineperioperative careambulatory surgery

Billing Code Overview

HCPCS Level II code J1790 represents an injection of droperidol, up to 5 mg. This code describes a single administration of the antiemetic and antipsychotic agent droperidol when given by injection.

Service type: Therapeutic medication administration
Typical site of service: Hospital-based settings, emergency department, ambulatory surgical centers, or other clinical settings where injectable antiemetic or sedative agents are administered

Clinical & Coding Specifications

Clinical Context

A 45-year-old male presents to the emergency department with acute severe nausea and vomiting after a migraine and failed oral antiemetics. After triage and evaluation, the emergency physician administers an intramuscular or intravenous antiemetic/anti-psychotropic agent, J1790 (injection, droperidol, up to 5 mg), for rapid control of nausea, agitation, or refractory vomiting. Vital signs and QTc interval are assessed prior to administration per institutional policy; continuous cardiac monitoring is available when given intravenously. Typical workflow: triage → nursing assessment and medication reconciliation → EKG if indicated → informed consent for parenteral medication → administration of J1790 (IM/IV) → observation for adverse effects (sedation, extrapyramidal symptoms, QT prolongation) → reassessment and discharge or admission based on response.

Coding Specifications

Modifier	Description	When to Use
`23`	Unusual Anesthesia	When general anesthesia was unexpectedly required in conjunction with the procedure (rare for `J1790`).
`25`	Significant, Separately Identifiable E/M Service	When an evaluation and management visit is performed on the same day as `J1790` and is significant and separately documented.
`52`	Reduced Services	When a partial dose or abbreviated service is intentionally provided relative to full service.
`53`	Discontinued Procedure	When administration was begun but discontinued due to patient reaction or change in condition.
`59`	Distinct Procedural Service	When `J1790` is distinct from other services or injections performed same day.
`62`	Two Surgeons	Rarely applicable; used when two surgeons are involved in a surgical procedure where `J1790` is administered intraoperatively.
`76`	Repeat Procedure by Same Provider	When the same provider administers an additional dose of `J1790` during the same encounter.
`78`	Return to OR for Related Procedure	Not commonly used but applies if patient returns to OR and droperidol is administered related to that return.
`80`	Assistant Surgeon	When an assistant surgeon participates in a procedure where `J1790` is administered intraoperatively.
`JW`	Drug Wastage Reported Separately	When discarded portion of single-use drug vial is reported per carrier policy (if allowed).
`JZ`	No Anticipated Drug Waste	When no drug waste is expected or reported.
`XE`*	Separate Encounter, Distinct Service	(Note: `XE` not in provided list; excluded)

Taxonomy Code	Specialty	Notes
`208000000X`	Emergency Medicine	Most common specialty administering `J1790` for acute agitation, nausea, or sedation in ED settings.
`208800000X`	Anesthesiology	May administer droperidol intraoperatively or for postoperative nausea/vomiting prophylaxis.
`208600000X`	Psychiatry	May use droperidol for acute severe agitation in monitored settings.
`207P00000X`	Family Medicine	May administer in urgent care settings for nausea/emesis management.
`363A00000X`	Critical Care Medicine	Used in ICU settings for sedation or antiemetic effect under monitoring.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`R11.2`	Nausea with vomiting, unspecified	Common indication for droperidol to control refractory vomiting.
`G43.909`	Migraine, unspecified, not intractable, without status migrainosus	Migraines with severe vomiting where parenteral antiemetics are used.
`F41.9`	Anxiety disorder, unspecified	Acute agitation or severe anxiety episodes where droperidol may be used for sedation in monitored settings.
`R45.82`	Acute stress reaction	Situations of acute agitation where short-acting parenteral sedatives/antipsychotics are used.
`T88.7XXA`	Unspecified adverse effect of drug or medicament, initial encounter	Relevant when documenting adverse reactions to antiemetic or sedative medications such as extrapyramidal symptoms.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly used for billing the injection administration when `J1790` is given intramuscularly.
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	May be used when droperidol is administered as part of an IV infusion protocol (less common).
`93000`	Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	Performed prior to IV droperidol in patients at risk for QT prolongation.
`99284`	Emergency department visit, moderate complexity	Typical E/M level accompanying administration of `J1790` in the ED when significant evaluation is performed.
`96374`	Therapeutic, prophylactic, or diagnostic injection; each additional sequential IV push of a new substance/drug	Used when additional IV pushes of medications are administered during the same encounter alongside `J1790`.